ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Possible contribution of the STAT3 signaling pathway to disseminated intravascular coagulation (DIC) in mice with cecal ligation and puncture-induced sepsis.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Disseminated intravascular coagulation (DIC) is a serious disorder characterized by the systemic activation of blood coagulation and is a frequent complication in sepsis. Once septic patients develop DIC, it leads to a poor outcome. Appropriate DIC prevention strategies will be helpful for the management of sepsis. In this study, we attempted to identify coagulation disorder in mice with cecal ligation and puncture (CLP)-induced sepsis, a clinically relevant animal model of sepsis, and to provide pharmacological approaches for preventing the occurrence of DIC in sepsis. In CLP-induced septic mice, the blood platelet count was significantly declined, prothrombin time was significantly prolonged, the coagulation blood markers D-dimer and thrombin-antithrombin complex were significantly elevated, microvascular fibrin deposition and thrombus formation were detected in liver and kidney tissues, and thrombin levels in liver tissues were prominently up-regulated in comparison with sham-operated controls, implying that coagulation was developed in this animal model of sepsis. These changes were almost entirely abrogated when the signal transducers and activators of transcription 3 (STAT3) pathway was inhibited by transfection of STAT3 decoy oligodeoxynucleotides (ODNs) or pharmacological intervention with stattic. CLP-induced septic mice exhibited significant increases in tissue expression of plasminogen activator inhibitor (PAI-1) and tissue factor (TF), both of which play a crucial role in thrombogenesis. STAT3 ODN transfection strikingly suppressed overproduction of PAI-1 and TF after CLP. Nuclear factor-κB inhibition also reduced the PAI-1 and TF up-regulation but was without effect on prolonged prothrombin time in CLP mice. Our results suggest that inhibition of the STAT3 signaling pathway provides a potential benefit for preventing the development of DIC in sepsis.
Indexed as
Identifiers
41284000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.